semaglutide 2.4 mg (Wegovy) has demonstrated weight loss of 10-15% in clinical trials, while other GLP-1 medications and lower doses typically produce more modest results
At Gennev, we believe that healthy bodies come in all shapes and sizes, and that if weight management is something youre interested in, it should be one part of a comprehensive plan to have the kind of healthy life you want, regardless of your age, where you are in menopause, and whats going on in your world
At 26 weeks, it was found that the group of participants who were in the Rybelsus 14mg group, had a 42% greater weight reduction compared to the liraglutide 1.8 mg group
= Hormon- und Stoffwechselforschung = Hormones metabolisme (2008) 40(9):593606
The short-term effects are unknown
Personalized Treatment Regimen Dosage, frequency and program length are determined according to the provider-approved plan